195 Followers on Owler

Regulus

Therapeutics is a California-based biopharmaceutical firm that develops and markets microRNA therapies for the treatment of inflammatory and metabolic disorders... Read more
OverviewCompetitorsFundingNews & Insights

Regulus

Therapeutics is a California-based biopharmaceutical firm that develops and markets microRNA therapies for the treatment of inflammatory and metabolic disorders... Read more
Regulus President & CEO: Joseph P. Hagan

President & CEO

Joseph P. Hagan

CEO Approval Rating

81/100

2007

PublicAcquired by Novartis AGNASDAQRGLS

Pharmaceuticals & Biotechnology
Biotechnology
28342836 NAICS listing

Annual Revenue
$10M
Employees
30
Funding
$364M

News

Acquisition
Apr 30, 2025
GlobeNewswire
Regulus Was acquired by Novartis AG for $1.7B

Regulus Competitors

1aTyr Pharma
Unlock -2 + competitors

Trending Companies